Abstract | CONTEXT: CASE REPORT: We herein report a case where islet allotransplantation was carried out in a patient who had undergone total pancreatectomy. Following two islet infusions, he became insulin independent with excellent glycemic control and remains so currently, more than four years after his second islet infusion. Side effects from immunosuppressive therapy were minimal. DISCUSSION: Islet allotransplantation can be considered in selected individuals post- pancreatectomy. The absence of autoimmunity may be advantageous for long term graft function relative to islet allotransplantation in type 1 diabetic recipients.
|
Authors | Angela Koh, Sharleen Imes, Andrew Mark James Shapiro, Peter A Senior |
Journal | JOP : Journal of the pancreas
(JOP)
Vol. 14
Issue 4
Pg. 428-31
(Jul 10 2013)
ISSN: 1590-8577 [Electronic] Italy |
PMID | 23846941
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
|
Topics |
- Blood Glucose
(metabolism)
- Diabetes Mellitus, Type 1
(blood, etiology, surgery)
- Humans
- Islets of Langerhans Transplantation
(methods)
- Male
- Middle Aged
- Pancreatectomy
(adverse effects, methods)
- Postoperative Complications
(blood, etiology, surgery)
- Transplantation, Autologous
- Treatment Outcome
|